Decreased insulin action, impaired insulin secretion and increased adiposity are important risk factors for development of type 2 diabetes. These risk factors are present even when individuals have both normal fasting and two hour glucose concentrations indicating a very early role for decreased insulin secretion in the development of type 2 diabetes. In previous work we found that a bimodally expressed gene in muscle tissue, HLA-DRB1, was associated with lower risk for diabetes and higher insulin secretion in Pima Indians. As this protective HLA haplotype system indicates involvement of autoimmunity in progression to type 2 diabetes in Pima Indians we performed a pilot study in individuals with and without the HLA-DRB1 locus who were also discordant for diabetes status, examining both immunoprofiling of over 9,000 potential proteins and T-cell receptor genes. From among those 9,00 proteins study we have selected 90 antibodies with significantly increased concentrations in those with diabetes and tested these in a large 45 individuals with diabetes and lacking HLA-DRB1 and 45 individuals with normal glucose regulation with the HLA-DRB1 allele. These individuals were matched for age and sex. Of the selected 90 proteins, ten again had higher signals in those with diabetes. Once these results are confirmed, we would test these potential biomarkers for type 2 diabetes in an even larger co-hort. We also sequenced the complementary defining region 3 (CDR3) in the T cell receptor in these same individuals. We found that several genes which combine to define the CDR3 region differed significantly in frequency between those with and without diabetes and we found that the length of the CDR3 region is shorter in those with diabetes.. We then sequenced CDR3 regions in a larger number of individuals without the protective HLA haplotype and normal glucose regulation at the time of the visit who also have measures of insulin action and secretion. In this larger co-hort we confirmed that one of the genes more frequent in those with diabetes (V gene 7-8) in the initial cohort predicted development of diabetes, as did shorter CDR3 length. We are continuing to investigate additional factors which control insulin secretion and insulin action. Individuals without diabetes who are undergoing bariatric surgery using the following techniques: Roux-en-Y gastric bypass (RYGBP), laporoscopic band, or gastric sleeve have undergone measures of insulin action, insulin secretion and meal tests prior to and one month following the surgery. Results indicate that individuals who underwent RYGBP had improvements in insulin action hepatic insulin sensitivity, and more rapid glucose and insulin responses during meal tests. This explains the greater improvement in glycemia seen in those with diabetes undergoing RYGBP compared with other the laporoscopic band. Although glucagon like peptide-1 (GLP-1) also increased more during the meal in those who underwent RYGBP, the timing did not indicate that this increase played a role in the increase insulin release. Other gastrointestinal peptides did not differ between the groups except for pancreatic polypeptide, a marker of vagal nerve activity, which decreased significantly during the meal following RYGBP Previous predictors of weight gain based on this study have included, higher respiratory quotient, higher insulin mediated glucose uptake, lower free T3, and relatively lower energy expenditure. Variability in energy expenditure is a mediator of weight change, and we have continued to evaluate factors related to metabolic rate. We confirmed this association between lower energy expenditure relative to body size as a predictor of weight gain in a larger cohort with longer follow-up. Furthermore, we were able to demonstrate that lower energy expenditure also predicted gain in fat mass. In a different analysis of weight trajectories in adulthood, we were also able to demonstrate a weight stable group had relatively higher 24 hour energy expenditure compared to all the groups who gained weight, regardless of starting weight. The thermic effect of food and the energy cost of arousal are overlapping and difficult to measure components of energy expenditure. By examining timepoint data from our metabolic chambers, we were able to estimate these components (which we termed awake fed thermogenesis (AFT)) which accounted for approximately 10% of total energy expenditure. We found that lower AFT predicted weight gain, but only in individuals with BMI ≥29 kg/m. This indicates that increased insulation associated with adiposity leads to lower cost of metabolizing macronutrients. As individuals gain weight, their energy expenditure increases more than would be expected based on their increased weight. We have found that increased fasting plasma glucose which may be a marker for increase hepatic glucose production explains part of the large than expected increased EE. Genetic factors underlie adiposity and its risk factors. Mutations in the melanocortin 4 receptor gene are associated with increased body mass index and lower 24 hour energy expenditure in humans. Individuals with MC4R mutations have accelerated weight gain in childhood but not in adulthood indicating a more potent effect of this mutation in early life. Furthermore, we found that presence of MC4R mutations predicted development of diabetes in childhood independent of body weight. In an analysis of weight gain trajectories in childhood we have confirmed that children with MC4R mutations cluster into the highest weight gain trajectory. The mechanism by which MC4R leads to hyperphagia and weight gain is not clear. One possible mediator is brain derived neurotrophic factor (BDNF) a downstream effector of MC4R signaling which has been implicated in childhood hyperphagia and weight gain. However, serum BDNF did not differ between individuals with and without MC4R mutations. Recently a more common single nucleotide polymorphism (SNP) has been identified that is associated with increased BMI in Pima Indians. This common SNP is near the promoter region and is also associated with lower energy expenditure and increased ad libitum food intake.

Project Start
Project End
Budget Start
Budget End
Support Year
32
Fiscal Year
2014
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
Zip Code
Heinitz, Sascha; Basolo, Alessio; Piaggi, Paolo et al. (2018) Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage. J Clin Endocrinol Metab 103:1077-1087
Heinitz, Sascha; Basolo, Alessio; Piomelli, Daniele et al. (2018) Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure. J Clin Endocrinol Metab :
Piaggi, P; Vinales, K L; Basolo, A et al. (2018) Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms. J Endocrinol Invest 41:83-89
Heinitz, Sascha; Piaggi, Paolo; Bogardus, Clifton et al. (2018) Decline in the acute insulin response in relationship to plasma glucose concentrations. Diabetes Metab Res Rev 34:
Paddock, Ethan; Looker, Helen C; Piaggi, Paolo et al. (2018) One-Hour Plasma Glucose Compared With Two-Hour Plasma Glucose in Relation to Diabetic Retinopathy in American Indians. Diabetes Care 41:1212-1217
Piaggi, Paolo; Masindova, Ivica; Muller, Yunhua L et al. (2017) A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians. Diabetes 66:2284-2295
Chang, Douglas C; Piaggi, Paolo; Krakoff, Jonathan (2017) A Novel Approach to Predict 24-Hour Energy Expenditure Based on Hematologic Volumes: Development and Validation of Models Comparable to Mifflin-St Jeor and Body Composition Models. J Acad Nutr Diet 117:1177-1187
Frankl, Joseph; Piaggi, Paolo; Foley, James E et al. (2017) In Vitro lipolysis is associated with whole-body lipid oxidation and weight gain in humans. Obesity (Silver Spring) 25:207-214
Chang, Douglas C; Piaggi, Paolo; Hanson, Robert L et al. (2017) Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: A case-control study. Diabetes Metab Res Rev :
Heinitz, S; Piaggi, P; Vinales, K L et al. (2017) Specific skeletal muscle sphingolipid compounds in energy expenditure regulation and weight gain in Native Americans of Southwestern heritage. Int J Obes (Lond) 41:1585-1593

Showing the most recent 10 out of 42 publications